https://doi.org/10.4081/monaldi.2024.2907
Transplantation of heterozygous familial hypercholesterolemia living donor liver resulting in early myocardial infarction: a possible dangerous link
Submitted: January 9, 2024
Accepted: January 14, 2024
Published: January 16, 2024
Accepted: January 14, 2024
Abstract Views: 435
PDF_EARLY VIEW: 254
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Living donor liver transplantation (LDLT) is a lifesaving procedure that is often curative for several liver diseases. Familial hypercholesterolemia (FH) is a metabolic disease that results from an autosomal dominant mutation in the low-density lipoprotein receptor; yet, young patients with FH can live years without detection. Herein, we report a case of a patient who developed early myocardial infarction (MI) after having a transplant from a donor with undetected heterozygous FH. This was a 67-year-old female with non-alcoholic steatohepatitis-related liver cirrhosis, free from coronary artery disease, who underwent LDLT from her daughter, a 45-year-old female with no past medical history. One year post-transplant, she presented with an acute MI with a large atherosclerotic burden. Genetic analysis confirmed heterozygous FH in the donor but not in the recipient. This case emphasizes the importance of incorporating a thorough clinical history and lipid profile into pre-transplant testing for both the recipient and donor, as well as aggressive lipid-lowering therapy post-transplantation to avoid cardiovascular complications.
Goldaracena N, Barbas AS. Living donor liver transplantation. Curr Opin Organ Transplant 2019;24:131-7.
DOI: https://doi.org/10.1097/MOT.0000000000000610
Trotter JF. Selection of donors for living donor liver transplantation. Liver Transpl 2003;9:S2-7.
DOI: https://doi.org/10.1053/jlts.2003.50221
Neuberger J. An update on liver transplantation: a critical review. J Autoimmun 2016;66:51-9.
DOI: https://doi.org/10.1016/j.jaut.2015.08.021
Nikkilä K, Åberg F, Isoniemi H. Transmission of LDLR mutation from donor through liver transplantation resulting in hypercholesterolemia in the recipient. Am J Transplant 2014;14:2898-902.
DOI: https://doi.org/10.1111/ajt.12961
Kholaif N, Mohamed TI, Alharbi IS, et al. Management and clinical outcomes of patients with homozygous familial hypercholesteremia in Saudi Arabia. Monaldi Arch Chest Dis 2023;93. doi:10.4081/monaldi.2023.2503
DOI: https://doi.org/10.4081/monaldi.2023.2503
Al-Rasadi K, Al-Waili K, Al-Sabti HA, et al. Criteria for diagnosis of familial hypercholesterolemia: a comprehensive analysis of the different guidelines, appraising their suitability in the Omani Arab population. Oman Med J 2014;29:85-91.
DOI: https://doi.org/10.5001/omj.2014.22
Setia N, Saxena R, Arora A, Verma IC. Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations. Atherosclerosis 2016;255:31-6.
DOI: https://doi.org/10.1016/j.atherosclerosis.2016.10.028
Gilroy R, Heronemus M, Schmitt T, Moriarty P. Donors with familial hypercholesterolemia and clinical outcome in liver transplant recipients. Transplantation 2014;98:796.
DOI: https://doi.org/10.1097/00007890-201407151-02729
Popescu I, Habib N, Dima S, et al. Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: seven-yr follow-up. Clin Transplant 2009;23:565-70.
DOI: https://doi.org/10.1111/j.1399-0012.2008.00935.x
Liu C, Niu DM, Loong CC, et al. Domino liver graft from a patient with homozygous familial hypercholesterolemia. Pediatr Transplant 2010;14:E30-3.
DOI: https://doi.org/10.1111/j.1399-3046.2009.01133.x
Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
DOI: https://doi.org/10.1056/NEJMoa0807646
He K, Wang J, Shi H, et al. An interspecies study of lipid profiles and atherosclerosis in familial hypercholesterolemia animal models with low-density lipoprotein receptor deficiency. Am J Transl Res 2019;11:3116-27.
Ethics Approval
The study was approved by the office of research affairs and the Ethical Committee of our Institution (approval number: RAC 2191111).How to Cite
Kholaif, Naji, Lin Batha, Isra Elmahi, Sulaiman Alnaser, Sultan Alzaher, Norah Almallohi, Mosaad Alhussein, Dana Alhalees, and Ahmed Alshehri. 2024. “Transplantation of Heterozygous Familial Hypercholesterolemia Living Donor Liver Resulting in Early Myocardial Infarction: A Possible Dangerous Link”. Monaldi Archives for Chest Disease, January. https://doi.org/10.4081/monaldi.2024.2907.
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Ugo Corrà, Andrea Giordano, Marco Gnemmi, Fabiana Isabella Gambarin, Claudio Marcassa, Massimo Pistono, Cardiovascular disease patients and predictors of length of stay of residential of cardiac rehabilitation. A specific rehabilitation is mandatory in very old patients? , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Gian Francesco Mureddu, Stefano Nistri, Anna Maria Gori, Pompilio Faggiano, Biagio Fimiani, Antonio Maggi, Gianfranco Misuraca, Massimo Uguccioni, Luigi Tavazzi, Giovanni Battista Zito, Awareness and appropriateness of the management of preclinical heart failure in outpatient clinics in Italy: Insights from the VASTISSIMO study - EValuation of the AppropriateneSs of The preclInical phase (Stage A and Stage B) of Heart FaIlure Management in Outpatient Clinics in Italy , Monaldi Archives for Chest Disease: Vol. 89 No. 1 (2019)
- Nevin Taci Hoca, Ebru Ünsal, Koza Murat, Arzu Ertürk, Nermin Çapan, Can serum progranulin level be used as a prognostic biomarker in non-small cell lung cancer? , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
- Ricardo Alves Pinto, Catarina Amaral Marques, Tânia Proença, Miguel Martins Carvalho, Cristina Cruz, Filipe Macedo, The world upside down – after 20 years of follow-up of dextro-transposition of the great arteries , Monaldi Archives for Chest Disease: Vol. 94 No. 1 (2024)
- Mariana Gomes Tinoco, Margarida Castro, Luísa Pinheiro, Tamara Pereira, Margarida Oliveira, Sílvia Ribeiro, Nuno Ferreira, Olga Azevedo, António Lourenço, “Hot phase” clinical presentation of biventricular arrhythmogenic cardiomyopathy: when the perfect electrical storm spontaneously stops , Monaldi Archives for Chest Disease: Early Access
- Andrea Salzano, Domenico Sirico, Luisa Golia, Valentina Faga, Martina Flora, Eduardo Bossone, Antonio Cittadini, The portopulmonary hypertension: an overview from diagnosis to treatment , Monaldi Archives for Chest Disease: Vol. 80 No. 2 (2013): Cardiac series
- Vaishali Verma, Sachin Sondhi, Rajesh Sharma, Kunal Mahajan, COVID-19 associated viral myocarditis: does it exist? , Monaldi Archives for Chest Disease: Vol. 90 No. 4 (2020)
- Afrah Alsomali, Abdullah Eltayeb, Sarah Aldosari, Maie AlShahid, Aly AlSanei, Ali AlEnazy, Olga Vriz, Recurrence of left ventricular pseudoaneurysm after multiple mitral valve replacements , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Andrea Palomba, Francesco Pelizzo, Mattia Canevari, Olga Vriz, Pulmonary edema in a young male with severe uncontrolled cardiovascular risk factors and pan-vascular atherosclerosis: a case report , Monaldi Archives for Chest Disease: Early Access
- Miguel Martins Carvalho, Tânia Proença, Ricardo Alves Pinto, Roberto Pinto, Filipe Macedo, Wernicke encephalopathy and beriberi disease presenting as STEMI-equivalent , Monaldi Archives for Chest Disease: Vol. 93 No. 4 (2023)
You may also start an advanced similarity search for this article.
